Aug 08, 2022
The Dystrophic Epidermolysis Bullosa treatment market has a promising outlook. Various gene therapies in different stages are in the pipeline.
Read More...
Aug 05, 2022
Currently, the PML Therapeutics pipeline mainly comprises early phase assets. Limited companies are investigating in PML treatment options.
Read More...
Aug 03, 2022
The role of Artificial Intelligence in Mental Health is growing at an immense pace. The application of AI is providing immense benefit to user
Read More...
Aug 01, 2022
Several late-stage therapies developed by leading players for generalized myasthenia gravis treatment are expected to enter the therapeutics market
Read More...
Jul 29, 2022
Currently, there is no effective curative ADPKD treatment. However, leading companies in the therapeutics segment are evaluating novel drugs.
Read More...
Jul 25, 2022
Bronchopulmonary Dysplasia Treatment Market is expected to showcase massive growth as several pharma companies are developing therapies
Read More...
Jul 22, 2022
The current Retinal Vein Occlusion treatment environment is restrictive. Roche and Regeneron are dominating the RVO therapeutics market.
Read More...
Jul 11, 2022
Genital Warts therapeutics market is expected to evolve immensely with the launch of emerging therapies, such as VP-102, and others
Read More...
Jul 08, 2022
The vaccines market is highly competitive, with numerous global and regional players in the market. Companies developing therapeutic vaccines
Read More...
Jul 01, 2022
Several therapies and vaccines are at the early stage of development for chlamydia treatment. Leading companies in the therapeutics market are actively working to develop new therapies.
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper